Stem Cell Therapeutics Strengthens CD47 Franchise With Acquistion of … – Marketwired (press release)
|
Stem Cell Therapeutics Strengthens CD47 Franchise With Acquistion of …
Marketwired (press release) (TSX VENTURE:SSS)(OTCQX:SCTPF), a biopharmaceutical immuno-oncology company developing cancer stem cell-related therapeutics, today announced that it has entered into an option agreement to exclusively license worldwide rights to a panel of fully … |
